908 Devices Inc (MASS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, 908 Devices Inc (MASS) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.08 Million) by net assets ($134.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of 908 Devices Inc to measure how many days the company can operate on defensive assets alone.
908 Devices Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how 908 Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
908 Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 908 Devices Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Summarecon Agung Tbk
JK:SMRA
|
0.015x |
|
Palladyne AI Corp
NASDAQ:PDYN
|
-0.114x |
|
M1 Kliniken AG
XETRA:M12
|
0.129x |
|
Australian Clinical Labs Ltd
AU:ACL
|
0.416x |
|
Amplitude Surgical SAS
PA:AMPLI
|
0.029x |
|
Guangdong Jialong Food Co Ltd
SHE:002495
|
0.018x |
|
Colonial Coal International Corp
V:CAD
|
-0.023x |
|
Propel Funeral Partners Ltd
AU:PFP
|
0.059x |
Annual Cash Flow Conversion Efficiency for 908 Devices Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of 908 Devices Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see 908 Devices Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $143.70 Million | $-23.69 Million | -0.165x | +37.55% |
| 2024-12-31 | $114.59 Million | $-30.25 Million | -0.264x | -74.32% |
| 2023-12-31 | $165.49 Million | $-25.06 Million | -0.151x | -37.89% |
| 2022-12-31 | $190.60 Million | $-20.93 Million | -0.110x | +18.97% |
| 2021-12-31 | $214.60 Million | $-29.08 Million | -0.136x | -556.11% |
| 2020-12-31 | $139.04 Million | $4.13 Million | 0.030x | -82.94% |
| 2019-12-31 | $-63.17 Million | $-11.00 Million | 0.174x | -1.77% |
| 2018-12-31 | $-50.18 Million | $-8.90 Million | 0.177x | -- |
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more